Bernard Lerer

Lerer's research focuses on understanding the biological basis of severe psychiatric disorders and developing safer, more effective treatments, particularly through novel pharmacological approaches and brain stimulation, and investigating the mechanisms of electroconvulsive therapy for depression. He has received the AE Bennet Award of the US Society of Biological Psychiatry (1984), the Distinguished Mentor Award of the Israel Society for Biological Psychiatry (2012), the Pacific Rim Association for Clinical Pharmacogenetics Werner Kalow Prize (2014), the Israel Psychiatric Association Lifetime Achievement Award (2015), and the Lifetime Achievement Award of the International Society for Affective Disorders (2019). Provided by Wikipedia